These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 11469005

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Specific COX-2 inhibitors. Also effective in arthritis?].
    Einecke D.
    MMW Fortschr Med; 2000 Jan 20; 142(3):10. PubMed ID: 10726454
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Gastric protective pain therapy. What is the advantage of new COX-2 inhibitors?].
    Hinz B, Brune K.
    MMW Fortschr Med; 2000 Mar 16; 142(11):39-40. PubMed ID: 10786088
    [No Abstract] [Full Text] [Related]

  • 7. [No loss of effectiveness with rofecoxib. Long-term control of rheumatoid pain].
    Einecke D.
    MMW Fortschr Med; 2002 Nov 14; 144(46):68. PubMed ID: 12534087
    [No Abstract] [Full Text] [Related]

  • 8. COX-2 inhibitors: new drugs for the management of pain and inflammation.
    Hutchins V, Hutchins B.
    Dent Today; 2001 Feb 14; 20(2):56-61. PubMed ID: 12524847
    [No Abstract] [Full Text] [Related]

  • 9. [COX-2 inhibitor in arthrosis. Discontinuation before operations not necessary].
    MMW Fortschr Med; 2001 Oct 18; 143(42):64. PubMed ID: 11697296
    [No Abstract] [Full Text] [Related]

  • 10. [Selective cox-2 inhibitors. Better tolerance than NSAID plus antacid].
    MMW Fortschr Med; 2004 Apr 08; 146(15):66. PubMed ID: 15373027
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Treatment of rheumatoid arthritis and osteoarthritis with COX-2-selective inhibitors: a managed care perspective.
    Hochberg MC.
    Am J Manag Care; 2002 Nov 08; 8(17 Suppl):S502-17. PubMed ID: 12458820
    [Abstract] [Full Text] [Related]

  • 14. [Current status of COX II inhibitors in therapy of rheumatoid arthritis in comparison with conventional non-steroidal anti-inflammatory agents. Attempt at an evaluation with regard to evidence-based medicine].
    Krüger K.
    Z Rheumatol; 2001 Dec 08; 60(6):481-4. PubMed ID: 11826746
    [No Abstract] [Full Text] [Related]

  • 15. An update on specific COX-2 inhibitors: the COXIBs.
    Gupta S, Crofford LJ.
    Bull Rheum Dis; 2001 Dec 08; 50(1):1-4. PubMed ID: 12092091
    [No Abstract] [Full Text] [Related]

  • 16. COX-2 inhibitors: better than traditional NSAIDs? Vioxx and Celebrex may be no less risky than NSAIDs.
    Atkinson HG.
    Health News; 2002 Aug 08; 8(8):5. PubMed ID: 12206146
    [No Abstract] [Full Text] [Related]

  • 17. [Clinical use of COX-2 inhibitors].
    Ristić GG, Stefanović DZ.
    Vojnosanit Pregl; 2001 Aug 08; 58(3):283-95. PubMed ID: 11548555
    [No Abstract] [Full Text] [Related]

  • 18. New versus old drugs for arthritis.
    Health News; 1999 Nov 20; 5(14):7. PubMed ID: 10624169
    [No Abstract] [Full Text] [Related]

  • 19. COX-2 inhibitors: no pain, no heart gain?
    Harv Heart Lett; 2001 Dec 20; 12(4):2-4. PubMed ID: 11751079
    [No Abstract] [Full Text] [Related]

  • 20. Cyclooxygenase 2 inhibitors.
    Kelley KW, Ramsey LA.
    Adv Nurse Pract; 2003 Mar 20; 11(3):22-4. PubMed ID: 12683165
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.